Plasma Protein Therapeutics Association (PPTA)/LinkedIn
Oct 4, 2025, 12:25
The Patient Experience In The US: Access To Plasma-Derived Medicines – PPTA Webinar
Plasma Protein Therapeutics Association (PPTA) posted on LinkedIn:
”Join PPTA for a candid conversation with patients who use plasma-derived medicines to treat their rare diseases. They’ll explain the challenges, successes, and hopes for the future of plasma- derived medicines during a free webinar moderated by PPTA President and CEO Anita Brikman.
Monday, Oct. 6 at 2 pm ET/ 11 am PT
Virtual webinar – free to attend
Secure your spot today.”
Keep up with Hemostasis Today.
-
Feb 24, 2026, 16:18Salmaan Dalvi: Mapping Rare Diseases Across East and Central Africa
-
Feb 24, 2026, 16:16Wolfgang Miesbach: Game‑Changing Data on Intensive FVIII Replacement in Haemophilia A with Hypertrophic Synovium
-
Feb 24, 2026, 16:01Is It Safe to Briefly Stop Anticoagulation After VTE? – RPTH Journal
-
Feb 24, 2026, 15:58Anastasia Conti: Honored to Receive the Roche Foundation Grant for Independent Research in Onco-Hematology
-
Feb 24, 2026, 15:55Courtney Lawrence: Targeted Donor Screening Reduces Transfusion-Transmitted Babesia Cases
-
Feb 24, 2026, 15:30Aswin K Mohan: Practical Tips for Preparing Before, During, and After Blood Donation
-
Feb 24, 2026, 15:24Stéphanie Forté: The Hidden Burden of Stroke in Adults Living with Sickle Cell Disease
-
Feb 24, 2026, 15:13Tagreed Alkaltham: Equity in Emergency Care Through a Blood Bank Lens
-
Feb 24, 2026, 14:57Joseph Raffaele: Can Improving Mitochondrial Quality in Immune Cells Alter Immune Aging Markers?